TEVA/N bonds
Below is the list of TEVA PHARMACEUTICAL INDUSTRIES corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
|---|---|---|---|---|---|---|---|---|---|
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 8.75% | 9 K | 91.00% | 0.25% | 2026-02-01 | 22.88 M USD | 1,000.00 USD | 1,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTEVA5034099Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 7.91% | 300 K | 99.88% | 7.13% | 2025-01-31 | 425.26 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTEVA P.FI.NL III 16/46 | 7.33% | 0 | 72.88% | 4.10% | 2046-10-01 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6.96% | 1 M | 99.25% | 6.75% | 2028-03-01 | 255 K USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4914602Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 6.44% | 0 | 101.25% | 7.13% | 2025-01-31 | 1.25 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 6.08% | 0 | 100.48% | 6.15% | 2036-02-01 | 789.43 M USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTFABTEVA P.FI.NL III 16/26 | 5.85% | 0 | 95.55% | 3.15% | 2026-10-01 | 3.38 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5.69% | 1.05 M | 98.01% | 5.13% | 2029-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5.67% | 1 M | 102.97% | 6.75% | 2028-03-01 | 1.25 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 5.60% | 300 K | 98.18% | 4.75% | 2027-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5.59% | 1.08 M | 108.61% | 7.88% | 2029-09-15 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5.55% | 400 K | 112.69% | 8.13% | 2031-09-15 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS219821395TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000 | 5.18% | 0 | 100.13% | 6.00% | 2025-01-31 | 410.61 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS181372460TEVA PH.F.NL.II 18/25 | 4.54% | 0 | 99.99% | 4.50% | 2025-03-01 | 494.35 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4.08% | 0 | 120.18% | 7.88% | 2031-09-15 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 4.02% | 0 | 101.57% | 4.38% | 2030-05-09 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 3.85% | 0 | 114.26% | 7.38% | 2029-09-15 | 800 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 3.71% | 0 | 92.96% | 1.63% | 2028-10-15 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 3.70% | 0 | 100.11% | 3.75% | 2027-05-09 | 1.1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 3.66% | 0 | 96.19% | 1.88% | 2027-03-31 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 2.09% | 0 | 99.30% | 1.00% | 2025-07-28 | 350 M CHF | 5,000.00 CHF | 5,000.00 CHF | Teva Pharmaceutical Finance Netherlands IV BV |
| TTEVA3666246IVAX LLC 1.875% 15-DEC-2024 | — | — | — | 1.88% | 2024-12-15 | 333 M USD | 1,000.00 USD | 1,000.00 USD | IVAX LLC |